Latest filing published 17 Aug 2020 for ResMed Inc.
Filing timeline
BuySaleInsider track record
Richard McHale: trading record in brief
All filings by Richard McHale on record concern ResMed Inc. Over a trading history stretching from 10 October 2017 to 13 August 2020, the count stands at 35 filings.
No open-market purchase appears, only 9 sales worth €5.2M. Besides market trades, the filings include 22 share grants and 4 option exercises. In 2020 alone, the filings show no purchases and 1 sale.
Most recently, on 17 August 2020, the filings show a share grant in ResMed Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Richard McHale
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,235 shares0ResMed Common StockSEC:0001127602-20-023726:0
- 3,000 shares@ US$172.637.9% of flowResMed Common StockSEC:0001127602-20-005078:0
- 3,000 shares@ US$146.103.2% of flowResMed Common StockSEC:0001127602-19-033779:0
- 15,731 shares@ US$146.3417.0% of flowResMed Common StockSEC:0001127602-19-033565:0
- 8,775 shares@ US$146.349.5% of flowResMed Common StockSEC:0001127602-19-033565:1
- 1,206 shares@ US$143.881.3% of flowResMed Common StockSEC:0001127602-19-032675:0
- 1,189 shares@ US$143.881.3% of flowResMed Common StockSEC:0001127602-19-032675:1
- 1,199 shares@ US$143.881.3% of flowResMed Common StockSEC:0001127602-19-032675:2
- 1,781 shares0ResMed Common StockSEC:0001127602-19-031079:0
- 7,195 shares0ResMed Common StockSEC:0001127602-19-026663:0
- 12,306 shares@ US$127.0611.5% of flowResMed Common StockSEC:0001127602-19-025470:0
- 244 shares@ US$58.240.1% of flowResMed Common StockSEC:0001127602-19-014605:0
- 244 shares@ US$105.050.2% of flowResMed Common StockSEC:0001127602-19-014605:1
- 1,079 shares@ US$58.240.5% of flowResMed Common StockSEC:0001127602-19-014605:2
- 1,079 shares@ US$105.050.8% of flowResMed Common StockSEC:0001127602-19-014605:3
- 4,907 shares@ US$58.242.1% of flowResMed Common StockSEC:0001127602-19-014605:4
- 4,907 shares@ US$105.003.7% of flowResMed Common StockSEC:0001127602-19-014605:5
- 21,616 shares@ US$58.249.1% of flowResMed Common StockSEC:0001127602-19-014605:6
- 21,616 shares@ US$105.0016.3% of flowResMed Common StockSEC:0001127602-19-014605:7
- 58 shares@ US$106.940.0% of flowResMed Common StockSEC:0001567619-18-008414:0
- 45 shares@ US$106.940.0% of flowResMed Common StockSEC:0001567619-18-008414:1
- 1,800 shares@ US$111.561.4% of flowResMed Common StockSEC:0001567619-18-007209:0
- 12,793 shares@ US$104.189.4% of flowResMed Common StockSEC:0001567619-18-006921:0
- 7,137 shares@ US$104.185.3% of flowResMed Common StockSEC:0001567619-18-006921:1
- 1,149 shares@ US$106.940.9% of flowResMed Common StockSEC:0001567619-18-006838:0
25 of 35 declarations
